Massimiliano Dall’Ora

Author

Also Known As

Dall'Ora, Massimiliano <1983>, Dall’Ora, Massimiliano, M. Dall'Ora, M. Dall’Ora, M. D’Allora, Massimiliano Dall'Ora, Massimiliano Dall’Ora

Publications

523

Citations

H-Index

Concepts

All Affiliations

University of Bologna Istituto Ortopedico Rizzoli University of Chieti-Pescara University of Modena and Reggio Emilia Weizmann Institute of Science

About

Massimiliano Dall’Ora is an author at University of Bologna specializing in brain metastases, virology, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	1	1	72
2	Cell Biology	1	1	72
3	Cellular Therapies	1	1	72
4	Immunology	1	1	72
5	Immunotherapy	1	1	72

Massimiliano Dall’Ora

Publications

458

Citations

H-Index

Page 1

	Year	Citations
GD2 CAR T cells against human glioblastoma Malvina Prapa, Chiara Chiavelli, Giulia Golinelli, npj Precision Oncology	2021	76
Systemic delivery of HER2-retargeted oncolytic-HSV by mesenchymal stromal cells protects from lung and brain metastases Valerio Leoni, Valentina Gatta, Arianna Palladini, Oncotarget Cell TherapyBrain MetastasesSynthetic VirologyImmunologyViral Pathogenesis	2015	72
Preclinical Therapy of Disseminated HER-2+ Ovarian and Breast Carcinomas with a HER-2-Retargeted Oncolytic Herpesvirus Patrizia Nanni, Valentina Gatta, Laura Menotti, PLoS Pathogens	2013	49
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors Valerio Gelfo, Maria Teresa Rodia, Michela Pucci, Oncotarget	2016	46
Calreticulin: Challenges Posed by the Intrinsically Disordered Nature of Calreticulin to the Study of Its Function Lilian Varricchio, Mario Falchi, Massimiliano Dall’Ora, Frontiers in Cell and Developmental Biology	2017	38
Combining three antibodies nullifies feedback-mediated resistance to erlotinib in lung cancer Maicol Mancini, Nadège Gaborit, Moshit Lindzen, Science Signaling	2015	37
Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 Carla De Giovanni, Giordano Nicoletti, Elena Quaglino, Breast Cancer Research	2014	36
HER2 isoforms co-expression differently tunes mammary tumor phenotypes affecting onset, vasculature and therapeutic response Arianna Palladini, Giordano Nicoletti, Alessia Lamolinara, Oncotarget	2017	23
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model Elisa Bianchi, Sebastiano Rontauroli, Lara Tavernari, Leukemia	2023	20
Anti-GD2 CAR MSCs against metastatic Ewing's sarcoma Giulia Golinelli, Giulia Grisendi, Massimiliano Dall’Ora, Translational Oncology	2021	17

Page 1